KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Accumulated Expenses (2016 - 2025)

Boston Scientific (BSX) has disclosed Accumulated Expenses for 17 consecutive years, with $3.2 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 15.43% to $3.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 billion through Dec 2025, up 15.43% year-over-year, with the annual reading at $3.2 billion for FY2025, 15.43% up from the prior year.
  • Accumulated Expenses hit $3.2 billion in Q4 2025 for Boston Scientific, up from $3.0 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.2 billion in Q4 2025 to a low of $1.9 billion in Q1 2023.
  • Historically, Accumulated Expenses has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2024.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 1501.32% in 2021 and later dropped 18.36% in 2022.
  • Year by year, Accumulated Expenses stood at $2.4 billion in 2021, then dropped by 11.33% to $2.2 billion in 2022, then increased by 22.5% to $2.6 billion in 2023, then increased by 4.8% to $2.8 billion in 2024, then increased by 15.43% to $3.2 billion in 2025.
  • Business Quant data shows Accumulated Expenses for BSX at $3.2 billion in Q4 2025, $3.0 billion in Q3 2025, and $2.8 billion in Q2 2025.